Intellia Therapeutics, Inc.

NTLA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $340.7M $273.1M $75.8M
Accounts Receivable $10.5M $6.5M $1.0M
Inventory — — —
Total Current Assets $354.8M $281.3M $77.6M
Property, Plant & Equipment $15.3M $10.6M $2.7M
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $376.2M $299.0M $82.1M
Liabilities
Accounts Payable $2.2M $4.7M $1.4M
Total Current Liabilities $31.4M $30.7M $10.7M
Long-Term Debt — — —
Total Liabilities $75.6M $89.1M $103.3M
Stockholders' Equity
Retained Earnings $-121.1M $-53.6M $-21.9M
Total Stockholders' Equity $300.6M $209.8M $-21.2M
← Newer Page 2 of 2 Older →